Wird geladen...
Screening for Prostate Cancer in the US? Reduce the harms and keep the benefit
While the benefit of prostate specific antigen (PSA) based screening is uncertain, a significant proportion of screen-detected cases is overdiagnosed. In order to make screening worthwhile, it is necessary to find policies that minimize overdiagnosis, without significantly increasing prostate cancer...
Gespeichert in:
| Veröffentlicht in: | Int J Cancer |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452024/ https://ncbi.nlm.nih.gov/pubmed/25123412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29136 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|